Originally published on Trial Site News.
On August 23, 2021, the US Food and Drug Administration (FDA) granted approval (or licensure) to the first ever COVID-19 mRNA gene therapy product by Pfizer/BioNTech, which from the onset was misbranded as a ‘vaccine.’
The Acting FDA Commissioner Janet Woodcock, M.D., said at the time: “The FDA’s approval of this v…